Eaton Vance Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Eaton Vance Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$61.5M	Buy	307,288 +537	+0.2%	+$107K	0.09%	219
2022 Q2	$44.7M	Buy	306,751 +523	+0.2%	+$76.3K	0.06%	288
2022 Q1	$50M	Buy	306,228 +262,893	+607%	+$42.9M	0.06%	306
2021 Q4	$7.35M	Sell	43,335 -674	-2%	-$114K	0.01%	688
2021 Q3	$8.29M	Buy	44,009 +2,518	+6%	+$474K	0.01%	602
2021 Q2	$7.03M	Sell	41,491 -4,378	-10%	-$742K	0.01%	685
2021 Q1	$6.48M	Sell	45,869 -103,799	-69%	-$14.7M	0.01%	671
2020 Q4	$19.5M	Sell	149,668 -64,315	-30%	-$8.36M	0.03%	423
2020 Q3	$31.2M	Sell	213,983 -6,743	-3%	-$982K	0.06%	286
2020 Q2	$32.7M	Buy	220,726 +112	+0.1%	+$16.6K	0.07%	254
2020 Q1	$24M	Buy	220,614 +34	+0%	+$3.7K	0.06%	269
2019 Q4	$25.4M	Sell	220,580 -24	-0%	-$2.76K	0.05%	289
2019 Q3	$17.7M	Hold	220,604	–	–	0.04%	338
2019 Q2	$16M	Sell	220,604 -131,129	-37%	-$9.51M	0.04%	345
2019 Q1	$32.9M	Buy	351,733 +313,942	+831%	+$29.3M	0.08%	238
2018 Q4	$2.76M	Hold	37,791	–	–	0.01%	637
2018 Q3	$3.31M	Hold	37,791	–	–	0.01%	632
2018 Q2	$3.72M	Sell	37,791 -35,841	-49%	-$3.53M	0.01%	584
2018 Q1	$8.77M	Buy	73,632 +36,766	+100%	+$4.38M	0.01%	537
2017 Q4	$4.68M	Buy	36,866 +5,000	+16%	+$635K	0.01%	533
2017 Q3	$3.74M	Sell	31,866 -83	-0.3%	-$9.75K	0.01%	552
2017 Q2	$2.55M	Hold	31,949	–	–	0.01%	621
2017 Q1	$1.64M	Sell	31,949 -100	-0.3%	-$5.12K	﹤0.01%	679
2016 Q4	$1.2M	Buy	32,049 +50	+0.2%	+$1.87K	﹤0.01%	694
2016 Q3	$2.17M	Hold	31,999	–	–	0.01%	571
2016 Q2	$1.78M	Sell	31,999 -100	-0.3%	-$5.55K	0.01%	582
2016 Q1	$2.02M	Buy	32,099 +200	+0.6%	+$12.6K	0.01%	550
2015 Q4	$3M	Sell	31,899 -100	-0.3%	-$9.41K	0.01%	489
2015 Q3	$2.57M	Hold	31,999	–	–	0.01%	505
2015 Q2	$3.84M	Buy	31,999 +21,600	+208%	+$2.59M	0.01%	436
2015 Q1	$1.09M	Buy	10,399 +75	+0.7%	+$7.83K	﹤0.01%	665
2014 Q4	$1M	Buy	+10,324	New	+$1M	﹤0.01%	660